Pacific Biosciences of California PACB
$1.63 −$0.13 (-7.39%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $1.63 +0.28%
Open$1.69
Prev close$1.76
Day range$1.61 – $1.73
Volume13.69M
Market cap$510.07M
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusHold
Analysts5
Average target$2.64+62.0% vs. price
- Buy 40%
- Hold 40%
- Sell 20%
Low $2.00Now $1.63Avg $2.64High $3.00
Recent rating changes
The last 20 actions on file set price targets from $1.00 to $3.00, averaging $2.35.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 9 Nov 2026 | UBS | HOLD | $2.70 |
| 5 Nov 2026 | CCORF | BUY | $3.00 |
| 5 Nov 2026 | Piper Sandler | HOLD | $3.00 |
| 5 Nov 2026 | Barclays | SELL | $2.00 |
| 23 Oct 2026 | Stephens | BUY | $2.50 |
| 7 Oct 2026 | Barclays | SELL | $1.25 |
| 11 Sep 2026 | CCORF | BUY | – |
| 17 Aug 2026 | CCORF | BUY | $3.00 |
| 6 Aug 2026 | TD Cowen | BUY | $3.00 |
| 6 Aug 2026 | CCORF | BUY | $3.00 |
| 6 Aug 2026 | Piper Sandler | HOLD | $2.00 |
| 5 Aug 2026 | Barclays | SELL | $1.25 |
| 8 May 2026 | TD Cowen | BUY | $3.00 |
| 8 May 2026 | CCORF | BUY | $3.00 |
| 8 May 2026 | Piper Sandler | HOLD | $2.00 |
| 8 May 2026 | Barclays | SELL | $1.50 |
| 14 Apr 2026 | Barclays | SELL | $1.00 |
| 19 Mar 2026 | CCORF | BUY | $3.00 |
| 6 Mar 2026 | Barclays | SELL | $1.50 |
| 13 Feb 2026 | CCORF | BUY | $3.00 |
No comments yet — be the first to weigh in on PACB.
Sign in to join the discussion.